- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 333/40 - Acide thiophène-2-carboxylique
Détention brevets de la classe C07D 333/40
Brevets de cette classe: 163
Historique des publications depuis 10 ans
|
10
|
7
|
9
|
11
|
4
|
6
|
9
|
6
|
7
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Allergan, Inc. | 2206 |
22 |
| Takeda Pharmaceutical Company Limited | 2718 |
11 |
| Vertex Pharmaceuticals Incorporated | 1597 |
8 |
| EA Pharma Co., Ltd. | 93 |
6 |
| Theravance Biopharma R&D IP, LLC | 425 |
6 |
| Nitto Denko Corporation | 8468 |
5 |
| Alcon, Inc. | 5719 |
5 |
| Astellas Pharma Inc. | 1030 |
4 |
| Ishihara Sangyo Kaisha, Ltd. | 658 |
4 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 856 |
4 |
| Bayer AG | 3430 |
3 |
| Northwestern University | 3513 |
3 |
| Iowa State University Research Foundation, Inc. | 814 |
3 |
| Celloram Inc. | 11 |
3 |
| Sumitomo Chemical Company, Limited | 9055 |
2 |
| JSR Corporation | 2522 |
2 |
| Millennium Pharmaceuticals, Inc. | 431 |
2 |
| ASKA Pharmaceutical Co., Ltd. | 100 |
2 |
| Chung-Ang University Industry-Academy Cooperation Foundation | 470 |
2 |
| Daiichi Sankyo Company, Limited | 1886 |
2 |
| Autres propriétaires | 64 |